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Abstract 14 
A 785 nm diode laser and probe with a 6 mm spot size were used to obtain spectra of 15 
stationary powders and powders mixing at 50 rpm in a high shear convective blender. 16 
Two methods of assessing the effect of particle characteristics on the Raman sampling 17 
depth for microcrystalline cellulose (Avicel), aspirin or sodium nitrate were compared: (i) 18 
the information depth, based on the diminishing Raman signal of TiO2 in a reference 19 
plate as the depth of powder prior to the plate was increased, and (ii) the depth at which a 20 
sample became infinitely thick, based on the depth of powder at which the Raman signal 21 
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of the compound became constant. The particle size, shape, density and/or light 22 
DEVRUSWLRQ FDSDELOLW\ RI WKH FRPSRXQGV ZHUH VKRZQ WR DIIHFW WKH ³LQIRUPDWLRQ´ DQG23 
³LQILQLWHO\ WKLFN´ GHSWKV RI LQGLYLGXDO FRPSRXQGV However, when different sized 24 
fractions of aspirin were added to Avicel as the main component, the depth values of 25 
aspirin were the same and matched that of the Avicel: 1.7 PP IRU WKH ³LQIRUPDWLRQ´26 
depth and 3.5 mm for WKH³LQILQLWHO\WKLFN´GHSWK. This latter value was considered to be 27 
the minimum Raman sampling depth when monitoring the addition of aspirin to Avicel in 28 
the blender. Mixing profiles for aspirin were obtained non-invasively through the glass 29 
wall of the vessel and could be used to assess how the aspirin blended into the main 30 
component, identify the end point of the mixing process (which varied with the particle 31 
size of the aspirin), and determine the concentration of aspirin in real time. The Raman 32 
procedure was compared to two other non-invasive monitoring techniques, near infrared 33 
(NIR) spectrometry and broadband acoustic emission spectrometry. The features of the 34 
mixing profiles generated by the three techniques were similar for addition of aspirin to 35 
Avicel. Although Raman was less sensitive than NIR spectrometry, Raman allowed 36 
compound specific mixing profiles to be generated by studying the mixing behaviour of 37 
an aspirin ± aspartame ± Avicel mixture. 38 
< Take in Figure 1> 39 
Keywords 40 
Raman spectrometry; process analytical technologies (PAT); powder blending; sampling 41 
depth; real-time monitoring; pharmaceuticals. 42 
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1. Introduction 44 
Raman spectrometry is proving to be a useful monitoring technique in the pharmaceutical 45 
industry, especially in secondary manufacturing [1, 2]. Considerable advantages have 46 
been demonstrated for analysis of tablets [3-18] and capsules [11, 19-23], particularly 47 
when transmission mode measurements were used [16-18, 20-24]. To ensure that 48 
pharmaceutical dosage forms contain the appropriate amount of active ingredient(s), the 49 
constituents must be blended to a homogeneous state. While transmission Raman 50 
spectrometry is suited for the analysis of tablets and capsules, the backscatter mode of 51 
measurement is more amenable for in situ analysis of larger unit operations such as 52 
powder blending. However, there are relatively few reports describing the use of 53 
backscatter Raman spectrometry for this purpose [25-27]; in contrast, use of in situ near 54 
infrared (NIR) spectrometry is far more common [28-33]. The mixing of diltiazem 55 
hydrochloride pellets and paraffinic wax was investigated by Vergote et al. using non-56 
invasive Raman spectrometry [26]. The process was monitored via a glass window in the 57 
side of the vessel using a laser spot of approximately 2 mm diameter. There was no 58 
significant difference in the intensity of the Raman signal when the diltiazem pellets were 59 
stationary or mixing at 50 rpm. Therefore, spectra could be recorded without stopping the 60 
mixing procedure and the Raman signal became constant when homogeneity had been 61 
reached. De Beer et al. [25] monitored the blending of Avicel PH 102, lactose DCL 21, 62 
dilitazem hydrochloride, and silicium dioxide using an invasive Raman probe; the end of 63 
the probe was flush with the inner surface of the mixing vessel wall. The mixing end-64 
point identified from the Raman measurements was comparable to that obtained using 65 
NIR spectrometry. Hausman et al. also reported the successful implementation of in-line 66 
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Raman spectrometry to monitor blending of azimilide dihydrochloride at low dose 67 
(1% w/w) [27]. 68 
One reason for the limited application of Raman spectrometry to powder 69 
processes is that conventional backscatter Raman systems typically employ optics that 70 
produce laser spot sizes smaller than 500 µm diameter, which results in the measurement 71 
of only a small volume of the sample. More representative sampling has been achieved 72 
by continuously rotating a sample during measurement [5, 6, 9, 10, 13, 14, 34] or by 73 
scanning at several positions [8, 34, 35], thereby increasing the sampling area. To 74 
overcome some of the sub-sampling limitations of conventional backscatter Raman 75 
systems, defocused probes or wide area sampling optics with laser beam diameters of 3 ± 76 
7 mm have also been investigated [15, 36-38]. Backscatter Raman measurements also 77 
exhibit a strong bias towards the upper surface layers of the sample. Monte Carlo 78 
simulations of the backscattered Raman signal from a 4 mm thick tablet using a 4 mm 79 
diameter laser spot have shown that 88% of the signal is generated in the top 1 mm layer 80 
of the tablet [24]. However, the increased sampling depth and area of wide area 81 
illumination probes results in significantly larger sampling volumes compared to 82 
conventional backscatter Raman probes. For example, it has been shown that Raman 83 
signals can originate from material 13 mm below the surface of a sample with a PhAT 84 
probe with a 7 mm spot size [38]. The sampling volume of a PhAT probe (3 mm spot 85 
size) was found to be approximately 1300 times larger than that of a non-contact Raman 86 
probe (150 µm spot size) and approximately 16700 times larger than that of an 87 
immersion probe (60 µm spot size) [36]. The larger sampling volume associated with the 88 
PhAT probe resulted in comparable results to NIR spectrometry for quantification of 89 
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mixtures of anhydrous and hydrated polymorphs; the sampling volume of the PhAT 90 
probe was found to be comparable to that for the NIR probe [39]. When mixtures of 91 
polymorphs of flufenamic acid (forms I and III) with different particle sizes were 92 
analysed using large and small spot size Raman probes, the wide area illumination probe 93 
was found to be less sensitive to particle size owing to the larger sampling volume 94 
measured with this probe [37]. 95 
This report describes the first use of a PhAT probe for in situ Raman monitoring 96 
of powder mixing in a high shear blender. The study included evaluation of the effect of 97 
particle size variations on the sampling depth that can be achieved with the PhAT probe 98 
to allow comparison with previously reported results obtained with probes of different 99 
optical configurations. In addition, the effect of particle size on the Raman signal was 100 
investigated; this was important as the effect of particle size on the backscatter Raman 101 
signal is highly dependent on the optical configuration of the probe employed [40]. 102 
Mixing profiles based on non-invasive Raman spectrometry have been assessed to 103 
compare the information they provide with mixing profiles produced by non-invasive 104 
NIR spectrometry and broadband acoustic emission (AE) spectrometry. Some advantages 105 
of Raman measurements over NIR spectrometry were identified for powder monitoring. 106 
107 
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2. Experimental 108 
2.1. Instrumentation 109 
2.1.1. Raman spectrometer 110 
A Kaiser Raman RXN1 spectrometer with a PhAT probe (Kaiser Optical Systems Inc., 111 
Ann Arbor. MI, USA) was used for all experiments except where stated below. The 112 
785 nm Invictus diode laser was operated at 400 mW at source. The laser beam was 113 
optically expanded to give a 6 mm spot size, a working distance of 254 mm and a depth 114 
of field of 50 mm. The probe to sample distance was 203 mm. For the sampling depth 115 
studies, spectra were acquired using an exposure time of 0.5 s and 1 accumulation. In situ 116 
Raman measurements were made through the glass wall of the mixing vessel during the 117 
powder blending experiments. A spectrum was acquired every 5 s with an exposure time 118 
of 2.5 s and 1 accumulation. The exposure time for each set of experiments was selected 119 
such that the largest Raman signal occupied approximately 60 ± 70% of the dynamic 120 
range of the CCD detector. 121 
For the experiment comparing Raman, NIR and AE, and the monitoring of the 122 
blending of a three component mixture, a different PhAT probe system was used. In this 123 
case, the 785 nm laser beam was optically expanded to give a 3 mm spot size and a 124 
working distance of 100 mm. The probe to sample distance was 100 mm. Spectra were 125 
acquired every 3 s, through the wall of the vessel, with an exposure time of 2 s and 1 126 
accumulation. 127 
A spectrum of aspartame was acquired using a Kaiser RXN1 spectrometer with a 128 
MR probe equipped with a non-contact optic (0.4 inch working distance and a laser spot 129 
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size of approximately 100 µm). An Invictus diode laser with a wavelength of 785 nm was 130 
employed, and was operated at 350 mW at the source. Aspartame was contained within a 131 
glass sample vial, which was placed in the off-line sample compartment, and the 132 
spectrum was acquired through the side of the vial using an exposure time of 4.0 s and 1 133 
accumulation.  134 
Data were acquired using HoloGRAMS software (Kaiser Optical Systems). A 135 
dark current spectrum was obtained before each set of experiments and subtracted 136 
automatically from each subsequent spectrum acquired. Data were exported into 137 
GRAMS/32 and converted to text files, which were subsequently imported into Matlab 138 
7.0 (Mathworks Inc., Natick, Massachusetts, USA) for analysis using the PLS_Toolbox 139 
version 3.04 (Eigenvector Research Inc., Manson, Washington, USA). As spectra of 140 
samples containing Avicel exhibited a sloping baseline arising from fluorescence, second 141 
derivative spectra were calculated throughout using the Savitzky ± Golay function with a 142 
second order polynomial and a 13 or 25 point filter width for data acquired using the 6 or 143 
3 mm laser spot size, respectively. 144 
2.1.2. Near infrared reflectance spectrometer 145 
Some measurements of powder mixing were obtained simultaneously by non-invasive 146 
Raman spectrometry, NIR spectrometry and broadband AE spectrometry. In situ NIR 147 
measurements were made through the glass wall of the vessel as described previously 148 
[31, 32] using a Zeiss Corona 45 NIR spectrometer (Carl Zeiss, Heidenheim, Germany). 149 
Measurements were acquired using Aspect software (Carl Zeiss) package and spectra 150 
stored as log(1/R) where R is the reflectance and was calculated from the intensity of 151 
light reflected by the sample relative to that for a reflectance standard. The integration 152 
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time was 32 ms and 10 scans were co-added for each acquired spectrum allowing 153 
measurements to be taken every 0.5 s. Data were exported as text files into Matlab for 154 
further analysis using PLS_Toolbox. First derivative spectra were calculated using the 155 
Savitzky ± Golay function with a 5 point filter width and second order polynomial. 156 
2.1.3. Acoustic emission 157 
The broadband AE monitoring equipment has been described previously [41]. A Nano 30 158 
transducer (Physical Acoustics Ltd, Cambridge, UK) was attached to the glass wall of the 159 
mixing vessel using a silicone-based vacuum grease (Dow Corning) and adhesive tape. 160 
The Nano 30 transducer was attached to a 2/4/6 series pre-amplifier (Physical Acoustics 161 
Limited). The pre-amplifier required a 28 V power supply (Physical Acoustics Limited) 162 
and the gain of the pre-amplifier was set to 60 dB. The pre-amplifier was connected to an 163 
Agilent 54642A oscilloscope using a 5 m length cable, which was linked to a computer via a 164 
GPIB to USB interface (Agilent Technologies).  165 
A data capture program, written in C
++
 by Douglas McNab and Robbie Robinson 166 
from the Centre of Ultrasonic Engineering (CUE) at the University of Strathclyde, 167 
enabled the cyclic sampling of the acoustic signals displayed on the oscilloscope and 168 
signals were saved as comma separated variable (CSV) files. Signals were acquired using 169 
a sampling rate of 2 MHz and the time interval between collection of signals was 2 s. A 170 
total of 450 signals were collected with each signal consisting of 4000 points. All 171 
acoustic signals were imported into Matlab for analysis. A power spectrum was 172 
calculated of each signal and three spectra were co-added to give a composite spectrum 173 
every 6 s. Signal areas were calculated by summing the intensities of the signals between 174 
0 and 400 kHz. 175 
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 176 
2.2. Powders 177 
Microcrystalline cellulose (Avicel PH-101; FMC, Cork, Ireland), aspirin, sodium nitrate 178 
(both from Sigma-Aldrich, Dorset, UK) and aspartame (provided by GSK, UK) were 179 
used. The Avicel particles have a tap density of 0.45 g cm
-3
, are granular in shape and 180 
have an average particle size of 50 ȝP$VSLULQparticles are low aspect ratio needles with 181 
an average particle size of 192 µm. Sodium nitrate particles are granular with an average 182 
particle size of 275 µm. Aspartame particles are high aspect needles (particle size was not 183 
measured). Average particle size information was obtained by laser diffraction, while 184 
density and shape information was obtained from the literature [42]. The powders were 185 
sieved through 10 cm diameter brass pan sieves (Endecotts Ltd, UK) to obtain different 186 
particle size ranges: <38, 38 ± 53, 53 ± 106, 150 ± 212, 212 ± 250, 250 ± 300, 300 ± 355 187 
and 355 ± 425 µm for Avicel; <106, 106 ± 150, 212 ± 250, 250 ± 300, 300 ± 355, and 425 188 
± 500 µm for aspirin; 150 ± 212, 212 ± 250, 250 ± 300, 300 ± 355, 355 ± 425, 425 ± 500 189 
and 500 ± 800 µm for sodium nitrate. The mid-point of the sieve range has been used in 190 
plots to represent each particle size fraction. 191 
 192 
2.3. Procedures 193 
2.3.1. Raman sampling depth studies 194 
A 2.68 mm thick layer of glass was placed on top of the inverted PhAT probe with a 195 
203 mm spacer attached (Figure 1a). A series of plastic plates, with a 30 mm diameter 196 
hole, were placed on top of the glass plate (Figures 1b and 1c). For investigation of 197 
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powder depths of 0 ± 4.48 mm, up to 16 × 0.28 mm thick plates were stacked on top of 198 
each other. A depth of 8.48 mm was obtained by placing an additional 4 mm thick plastic 199 
plate on top of the 16 plates. This combination of plates enabled sampling depths of 200 
4.48 mm to be measured. The powder was carefully placed into the hole in the plastic 201 
plates and levelled off using a razor blade, ensuring minimal compaction of the solid, and 202 
the mass of solid was recorded. A TiO2 reference layer (solid particles of TiO2 sealed 203 
between two microscope slides) was placed over the top layer of the powder (Figures 1b 204 
and 1c) with aluminium foil used as the final layer to reduce loss of laser and Raman 205 
photons from the upper surface of the TiO2 reference layer. Each corner of the 206 
microscope slide was labelled to ensure consistency in positioning, so that the same part 207 
of the TiO2 was analysed each time. A spirit level was placed on top of the glass above 208 
the spectrometer to ensure the radiation was pointing vertically upwards (see Figure 1a). 209 
Analysis of the variance of the Avicel signal at 1095 cm
-1
 revealed that the repeatability 210 
(expressed as the relative standard deviation (RSD) for n = 6) of the Raman 211 
measurements, positioning of the sample holder, the weighing procedure and the powder 212 
levelling process were 0.22, 0.34, 0.66, and 0.26%, respectively. 213 
The information depth was estimated using the TiO2 Raman signal at 397 cm
-1
.
 
As 214 
the depth of Avicel, aspirin or sodium nitrate increased, the TiO2 signal decreased until it 215 
became zero; hence, the information depth was defined as the point where the exciting 216 
laser can no longer penetrate the powder to generate a detectable Raman signal of the 217 
TiO2 reference layer. This type of approach has been used previously for information 218 
depth measurements in NIR reflectance spectrometry [31, 43, 44]. A second set of 219 
measurements was made based on the change in the intensity of the Raman signals of 220 
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Avicel, aspirin and sodium nitrate powders at 1095, 1606 and 1068 cm
-1
, respectively. In 221 
this case, the Raman signal increases with powder depth and then becomes constant, 222 
which defines the depth of powder at which the sample effectively becomes infinitely 223 
thick. These measurements were made to allow comparisons with the results of previous 224 
Raman studies [36, 40] and a study on reflectance NIR which used a similar protocol to 225 
assess the sampling depth for aspirin powders [31]. 226 
2.3.2. Powder blending 227 
The scaled-down convective mixer has been described previously [31, 32, 41]. The vessel 228 
has a pot size of about 500 mL, a radius of 4 cm and is made of glass. The impeller has 229 
three blades set 120° apart with a tilt angle of 45°; each blade is approximately 29 mm 230 
long and 12 mm wide. Powders were mixed at 50 rpm using a stirrer motor (IKA 231 
Eurostar, VWR International). 232 
For the mixing of two components, 75 g of unsieved Avicel PH-101 was placed 233 
into the vessel and mixed. After 120 s, different masses (0, 5, 10, 20, 30 or 40 g) of either 234 
unsieved or size fractions of sieved aspirin (<106, 250 ± 300 or 425 ± 500 µm) were 235 
added via a funnel positioned directly above the centre of the vessel and the powders 236 
were allowed to mix for a further 780 s. A further experiment was also conducted in 237 
which 25 g of unsieved aspirin and 25 g of unsieved aspartame was added to 75 g of 238 
unsieved Avicel PH-101 after 120 and 900 s, respectively; the total mixing time was 239 
2100 s. 240 
241 
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3. Results and Discussion 242 
3.1. Raman spectra 243 
Individual Raman spectra of aspirin, Avicel, and sodium nitrate measured through a glass 244 
plate, aspartame measured through the wall of a glass vial, the TiO2 reference layer, and 245 
the glass plate are illustrated in Figure 2. The Raman spectrum of TiO2 contains peaks at 246 
approximately 143, 397, 520 and 640 cm
-1
, indicating that the TiO2 is predominantly in 247 
the anatase phase [45]. The broad peak that appears at approximately 1400 cm
-1
 in all 248 
spectra in Figure 2 can be attributed to the glass plate. 249 
The TiO2 peak at 397 cm
-1
 was least affected by the other compounds and so was 250 
used for the information depth experiments. The peaks at 1068 and 1606 cm
-1
 in the 251 
sodium nitrate and aspirin spectra, respectively, were used to determine the depth at 252 
which the sample becomes infinitely thick. A small peak in the Avicel spectrum at 253 
approximately 1095 cm
-1 
was also measured, but was found to have poor sensitivity 254 
compared to the peaks selected for the other two compounds. 255 
 256 
3.2. Raman information depths for uncompacted powders 257 
A number of particle size ranges of Avicel, aspirin and sodium nitrate were analysed at 258 
increasing depths using the set-up illustrated in Figure 1, and the second derivative 259 
Raman spectral intensities were recorded. When the TiO2 peak at 397 cm
-1
 could no 260 
longer be detected, the depth of the selected powder was deemed to be the information 261 
depth limit. Figure 3 gives a summary of the information depths for the different particle 262 
size fractions of each compound. In each case, the information depth increased with 263 
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particle size before becoming constant at higher particle sizes. As the information depth 264 
for 300 ± 355 µm aspirin and 355 ± 425 µm sodium nitrate particles was found to be 265 
>4.48 mm and so could not be determined, values for these fractions were not included in 266 
Figure 3. The increase in information depth with particle size is consistent with Kubelka-267 
Munk theory. Diffuse reflectance decreases as particle size increases [46, 47] and 268 
consequently, the exciting laser intensity and the Raman signal generated can propagate 269 
through larger depths of powder. The differences in information depth for similar sizes of 270 
Avicel, aspirin and sodium nitrate particles <400 µm indicates that the particle shape, 271 
density and/or the light absorption capability of the compounds affect the depth of 272 
powder through which the TiO2 Raman spectrum can be measured. 273 
 As the intention was to use the PhAT probe to monitor powder blending in a 274 
mixer, information depths for TiO2 at 397 cm
-1
 were obtained for 10, 30 and 40 g of 275 
aspirin blended with 75 g Avicel PH-101 to give aspirin concentrations of 11.8, 28.6 and 276 
34.8% w/w, respectively. Three particle size ranges of aspirin were used: <106, 250 ± 277 
300 and 425 ± 500 µm. The information depth for each of the mixtures was in the range 278 
1.7 ± 2.0 mm, similar to the value for unsieved Avicel PH-101 (1.7 mm). These findings 279 
are similar to those obtained using NIR spectrometry, i.e. the information depth for the 280 
analyte compound is determined by the main component in the mixture [31]. 281 
 282 
3.3. Depth of powder at which sample becomes infinitely thick 283 
The depth of powder at which the 2
nd
 derivative Raman signal of Avicel (1095 cm
-1
), 284 
aspirin (1606 cm
-1
) or sodium nitrate (1068 cm
-1
) became constant was different for each 285 
compound and varied with particle size. The depth was found to be >3 mm for each 286 
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particle size range for Avicel. For sodium nitrate, the depth for the two smallest fractions 287 
(150 ± 212 µm and 212 ± 250 µm) was about 0.8 ± 1 mm, whereas for the other particle 288 
sizes, the value was 3.5 ± 3.9 mm. For aspirin, the depth initially increased with 289 
increasing particle size (from 3.8 to 4.5 mm) then decreased to 3.5 mm for the largest 290 
aspirin particle size range (425 ± 500 µm) analysed. When other peaks in the aspirin 291 
spectrum (292, 751 and 1045 cm
-1
) were measured, the information depth values were no 292 
different to those obtained at 1606 cm
-1
. In contrast, it has been shown that different 293 
peaks in the NIR spectrum of aspirin give different ³LQILQLWHO\ WKLFN´ VDPSOH GHSWKV 294 
owing to the different absorptivities of the first and second overtones in the spectrum (0.6 295 
± 1.1 mm and 1.1 ± 2.2 mm, respectively, depending on particle size) [31]. 296 
Wang et al. [40] investigated the effect of particle characteristics on the Raman 297 
VDPSOLQJGHSWKIRUDQXPEHURIFU\VWDOOLQHSRZGHUVXVLQJWKH³LQILQLWHO\WKLFN´PHWKRG298 
and found similar trends to those reported here. An increase in sampling depth was 299 
observed with average particle size in the range 108 ± 428 Pm for sodium nitrate; 300 
however, the values obtained (6 ± 15.5 mm) were much larger than those obtained in the 301 
present study. This is likely to be due to a combination of factors; the laser wavelength 302 
(514.5 nm) was shorter (sampling depth is wavelength dependent [48]) and a different 303 
optical configuration was employed, which has a strong influence on the sampling depth 304 
[40]. The sampling depth of a prototype Raman PhAT probe with a 3 mm diameter laser 305 
spot size was reported to be 2 mm for theophylline discs, using WKH ³LQILQLWHO\ WKLFN´306 
method [36]. However, it has been shown that the sampling depth is less for pressed 307 
material compared to uncompacted powders [40]. 308 
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When the previously mentioned particle size fractions of aspirin were mixed with 309 
unsieved Avicel, the intensity of the aspirin peak at 1606 cm
-1
 became constant at a depth 310 
of 3.5 ± 3.9 mm for all the mixtures. This indicates that similar to the information depth 311 
measurements, the depth at which an infinitely thick sample is achieved is influenced 312 
principally by the main component and is less affected by particle size variations of the 313 
minor component. If the sampling depth is 3.5 mm for mixtures of Avicel and aspirin and 314 
it is assumed that all layers within the 3.5 mm contribute equally to the Raman signal, 315 
then with a 6 mm diameter laser spot the sampling volume is 99.0 mm
3
. This equates to a 316 
mass of 0.045 g if the density (tap) of the powder is assumed to be that of Avicel 317 
(0.45 g cm
-3
). However, it can be estimated from the information depth plots that 318 
approximately 90% of the Raman signal is generated in the upper 1 mm layer of the 319 
powder; this is consistent with the results of Monte Carlo simulations by Matousek and 320 
Parker [24]. Therefore, the mass of sample that contributes to approximately 90% of the 321 
Raman signal is 0.013 g. 322 
The depth at which a sample becomes infinitely thick is generally greater than the 323 
information depth determined using a reference layer of TiO2. When a reference layer is 324 
used, the laser photons propagate through the powder to the reference layer where Raman 325 
photons of the reference material are generated. The backscattered Raman photons then 326 
propagate back through the powder where they are detected. Consequently, the Raman 327 
signal used to determine the information depth is only generated in the plane of the 328 
reference layer. In comparison, when a compound peak is used Raman photons can be 329 
generated throughout the entire depth of the powder. In such situations, the Raman signal 330 
decays slower than the exciting laser intensity [49, 50] and so it might be expected that 331 
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the sampling depth determined using this method will be greater. As the infinitely thick 332 
depth is determined using a signal from the sample powder, this will reflect more 333 
accurately the depth of material sampled by the Raman probe during powder blending. 334 
 335 
3.4. Effect of particle size on Raman intensities 336 
The second derivative Raman intensity of aspirin, Avicel and sodium nitrate was 337 
measured for each particle size range with a powder depth of 8.48 mm, well in excess of 338 
the depth required to achieve an infinitely thick sample for each compound (see Figure 339 
4). The aspirin peak intensity at 1606 cm
-1
 increases then decreases with increasing 340 
particle size, with the maximum (i.e. largest negative) signal intensity occurring at the 341 
intermediate particle size ranges. A similar trend was observed for the sodium nitrate and 342 
Avicel peak intensities at 1068 and 1095 cm
-1
, respectively. 343 
Kubelka-Munk theory states that diffuse reflectance increases as particle size 344 
decreases, which limits the volume of sample contributing to the Raman signal, and 345 
therefore, the Raman intensity should increase with increasing particle size [46, 47]. The 346 
Raman signals for aspirin, sodium nitrate and Avicel increase with particle size at lower 347 
particle sizes, in accordance with Kubelka-Munk theory; however, the signal decreases 348 
with an increase in particle size for larger particles. A similar trend to that observed in 349 
Figure 4 was observed in an earlier study by Wang et al. [40], when the probe to sample 350 
distance was increased to 10 mm to increase the unfocused spot diameter illuminating the 351 
sample to ~ 5 mm, and also by Hu et al. [37] when monitoring different particle sizes of 352 
flufenamic acid (form I) with small sampling volume probes (0.25 and 0.5 inch diameter 353 
immersion optics with a 60 Pm laser spot size). In both of these studies, the maximum 354 
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Raman signal intensity was observed for most samples in the intermediate particle size 355 
range [37, 40]. Although the variation in intensity with particle size predicted by 356 
Kubelka-Munk theory was not observed experimentally in a number of studies [37, 40, 357 
51], Wang et al. [40] demonstrated that there was a strong correlation between the Raman 358 
intensity and diffuse reflectance. The main reason for the difference is that Kubelka-359 
Munk theory assumes confocal excitation and collection, but in the absence of diffuse 360 
reflectance it is likely that the optical configurations employed in the experimental 361 
studies had incomplete overlap of the collection and excitation cones. So while an 362 
increase in diffuse reflectance decreases the sampling depth, it also increases lateral 363 
spreading of the exciting laser beam. This generates additional Raman photons in the 364 
region of the collection fibre, which caused an increase in the Raman signal with a 365 
decrease in particle size observed in studies by Wang et al. (with a 0.5 mm laser spot size 366 
and a probe to sample distance of 1 mm) [40] and by Pellow-Jarman et al. [51]. When the 367 
probe to sample distance was increased in the study by Wang et al. [40] (as discussed 368 
above), there was greater overlap between the collection and excitation cones and so the 369 
improved overlap of the two cones caused by lateral spreading of the excitation beam is 370 
less important; hence, the different trends observed at the two different sample to probe 371 
distances (and beam diameters). 372 
It is apparent that the variation in Raman signal observed with particle size is 373 
highly dependent on the optical arrangement employed [40]; it is a balance between 374 
signal enhancement through lateral spreading of the beam and signal reduction through a 375 
decrease in the sampling depth caused by diffuse reflectance. The PhAT probe mainly 376 
used in the present study (6 mm laser beam diameter), has good overlap of the excitation 377 
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and collection cones because of very weak divergence of the beam (i.e. close to a 378 
collimated beam with a large depth of field of approximately ±1 inch) [52]. 379 
Consequently, signal enhancement by the lateral beam spreading is less important and so 380 
the signal intensity is correlated to the sampling depth (as predicted by Kubelka-Munk 381 
theory) up to a certain particle size. For larger particle sizes, it may be that Raman 382 
photons are emitted outwith the collection volume of the PhAT probe owing to the 383 
greater propagation distances. 384 
 385 
3.5. Powder Blending 386 
Different masses and particle sizes of aspirin were added to 75 g Avicel PH-101 as it was 387 
agitated in the mixer. Example second derivative spectra obtained during the mixing of 388 
40 g of 250 ± 300 µm aspirin particles and Avicel PH-101 are shown in Figure 5; aspirin 389 
was added to the Avicel at 120 s. The Raman intensities of the aspirin peaks in the 390 
measured spectra increased as the mass of the aspirin was increased and correspondingly 391 
the Avicel peak intensity decreased. Mixing profiles were produced by plotting the 392 
second derivative Raman intensity against time for the aspirin peaks at 751 and 393 
1606 cm
-1
. The same trends were noted for measurements at each peak so only the results 394 
based on 1606 cm
-1
 are discussed. The mixing profiles for addition of 0 ± 40 g of the 250 395 
± 300 µm aspirin particles are shown in Figure 6. On addition of aspirin after 120 s, a 396 
large increase in Raman scattering occurred at 1606 cm
-1
 as a result of the mixing 397 
properties of the mixer, whereby the aspirin powder is drawn down towards the bottom of 398 
the vessel and then up the side of the vessel through the Raman observation zone. As 399 
mixing continued, the 2
nd
 derivative signal of aspirin became less negative as the mixture 400 
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became homogenous, with the larger masses of aspirin taking longer to achieve a more 401 
constant plateau signal. 402 
The mixing profiles for the other two particle sizes of aspirin were similar to those 403 
in Figure 6, however, the time taken to achieve a homogeneous mixture and the variation 404 
(peak-to-peak noise) of the profile at the plateau region increased with particle size for 405 
each mass of aspirin added. Bellamy et al. [31] obtained similar mixing profiles to those 406 
reported here when non-invasive NIR spectrometry was used to monitor the addition of 407 
aspirin to Avicel PH-101 in the same type of mixer. The lesser variability in the Raman 408 
profile signal at the plateau region when mixing smaller aspirin particles is due to the 409 
more consistent number of aspirin particles passing through the measurement region at 410 
any time than occurs for mixing of larger particle sizes; a similar phenomenon was 411 
observed by Bellamy et al. [31] for the NIR-based mixing profiles. The magnitude of the 412 
mean Raman signal in the plateau region at 700 ± 900 s was calculated for each of the 413 
mixing profiles and plotted against the mass of aspirin added. A linear response curve 414 
was generated for each particle size range of aspirin with slopes of -0.278 (R
2
 = 415 
0.986), -0.329 (R
2
 = 0.998), and -0.312 (R
2
 = 0.997) obtained for <106, 250 ± 300 and 416 
425 ± 500 µm particles, respectively. The lesser sensitivity obtained with the <106 µm 417 
particles is probably related to the different shape of these particles (more granular than 418 
needle-shaped) identified from microscope images. It is likely that with the large 419 
sampling volume used in this study, the change in the relative number of particles with 420 
aspirin particle size becomes less significant and so the spectrum obtained is still 421 
representative of the mass fraction of aspirin [37]. The estimated sampling volume with a 422 
mixing speed of 50 rpm and a sampling depth of 3.5 mm is 11095 mm
3
 (assuming all 423 
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layers contribute equally), which equates to a mass of 4.99 g. However, if 90% of the 424 
Raman signal is generated in the top 1 mm layer of powder, then most of the measured 425 
signal arises from 1.43 g of sample. 426 
The NIR method of Bellamy et al. [31] and a previously reported procedure for 427 
monitoring powder blending by broadband acoustic emission spectrometry [41] were 428 
used simultaneously with Raman spectrometry to compare the mixing profiles obtained 429 
by the three non-invasive techniques. Example profiles are given in Figure 7 for addition 430 
of 30 g aspirin to 75 g Avicel PH-101 mixing at 50 rpm. The features of the mixing 431 
profiles, including the end-point of blending to a homogeneous mixture, were similar for 432 
the three techniques, although the signal to noise was best for NIR and poorest for 433 
acoustic emission. De Beer et al. [25] also found in-line Raman and NIR spectrometry 434 
produced similar end-points (defined by the content uniformity method [30]) when used 435 
simultaneously to monitor mixing of Avicel PH-102, lactose DCL 21 and silicium 436 
dioxide in a high shear blender. However, there is clearer correspondence between the 437 
mixing profiles over the entire blending experiment in the present study, as the mixing 438 
profiles were derived from the spectral signals related to the added component and the 439 
spectral measurements were acquired at a higher acquisition frequency. Table 1 gives a 440 
comparison of the detection limit for unsieved aspirin mixing at 50 rpm in unsieved 441 
Avicel PH101 for non-invasive NIR spectrometry, Raman spectrometry, and acoustic 442 
emission. The detection limit calculated for Raman measurements was about an order of 443 
magnitude poorer than that obtained with NIR spectrometry with a Zeiss Corona 444 
instrument, but 5-fold better than the value obtained for acoustic emission with a Nano30 445 
transducer. 446 
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 Raman measurements were also obtained for addition of 25 g aspirin (after 120 s) 447 
and then 25 g aspartame (after 900 s) to 75 g of Avicel PH-101. Inspection of the second 448 
derivative spectra of the compounds revealed that mixing profiles could be plotted based 449 
on well resolved peaks for aspirin or aspartame with minimal interference from the other 450 
compounds; this is an advantage over NIR spectrometry for monitoring multiple 451 
component systems where multivariate techniques are generally needed to deconvolute 452 
the relative contributions from each compound. Example Raman mixing profiles based 453 
on the aspirin peak at 1606 cm
-1
 and the aspartame peak at 1006 cm
-1
 are shown in Figure 454 
8. As observed in Figure 6, on addition of aspirin to the mixer at 120 s, there was an 455 
initial large increase in the aspirin signal, which then decreased to a constant value; as 456 
expected, the aspartame response remained at approximately zero when aspirin was 457 
added to the Avicel. However, on addition of aspartame to the vessel at 900 s, there was a 458 
large change in the aspartame signal at about 1000 s. The oscillating mixing profile of 459 
aspartame between 1200 and 1600 s is characteristic of a cohesive particle [32]. The 460 
aspirin signal was affected by the addition of aspartame, initially increasing slightly 461 
owing to minor compaction of the powder mixture in the vessel followed by a reduction 462 
owing to dilution of the aspirin concentration as aspartame is blended in to the mixture. 463 
 464 
4. Conclusions 465 
This study has shown that non-invasive Raman spectrometry with an optically broadened 466 
spot size of 6 mm gives sampling depths of over 3 mm for measurement of aspirin in 467 
Avicel; this is greater than the value obtained for non-invasive NIR spectrometry in a 468 
previous study [31]. In situ Raman measurements can be used to produce mixing profiles 469 
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to study how the powders mix together, identify when the end point of mixing has 470 
occurred, and perform quantitative analysis in real time. Although less sensitive than a 471 
previously reported non-invasive NIR procedure, the Raman method could offer 472 
advantages when optimising mixing regimes for multi-component samples, as it may 473 
allow individual compound specific mixing profiles to be produced because of the 474 
WHFKQLTXH¶VJUHDWHUFKHPLFDOVSHFLILFLW\. 475 
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Table captions 627 
Table 1. Detection limit for aspirin in Avicel PH-101 mixing at 50 rpm for non-invasive 628 
NIR spectrometry, acoustic emission (AE) and Raman spectrometry. 629 
 630 
Technique Signal Detection limit/(% w/w)
a
 
NIR 1
st
 derivative of log(1/R) at 8956 cm
-1
 0.1 
Raman
 
2
nd
 derivative at 1606 cm
-1
 1.1 
AE Area between 0 and 400 kHz 5.2 
 631 
a
 Detection limit calculated from 3 times the standard deviation of the signal between 702 632 
and 900 s in the mixing profile for Avicel PH-101 alone (n = 34) divided by the 633 
sensitivity of the signal response for aspirin. The sensitivity was obtained from a plot of 634 
concentration (0 ±28.6% w/w for AE and 0 ±34.8% w/w for NIR and Raman) against 635 
average signal intensity between 702 and 900 s in the mixing profiles (n = 34). The NIR 636 
and Raman data were resampled to match the acquisition frequency of the AE 637 
measurements (every 6 s). 638 
 639 
640 
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Figure captions 641 
 642 
Figure 1. a) Raman PhAT probe set up for sampling depth experiments with powders, b) 643 
expansion of sample set up showing the glass plate, plastic plates and TiO2 reference 644 
layer, and c) end on view of sample set up.  645 
33 
 
 646 
Figure 2. Offset Raman spectra of a) aspirin, b) aspartame, c) Avicel PH-101, d) sodium 647 
nitrate, e) TiO2 reference layer (intensity reduced by a factor of 4) and f) 2.68 mm thick 648 
glass plate. All spectra, except for aspartame, were acquired using the PhAT probe with 649 
an exposure time of 0.5 s and 1 accumulation. The spectrum for aspartame was acquired 650 
using a MR probe with an exposure time of 4.0 s and 1 accumulation. 651 
  652 
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 653 
Figure 3. Information depths of Avicel, aspirin and sodium nitrate of different particle 654 
sizes, based on measurements of the TiO2 peak at 397 cm
-1
. 655 
  656 
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 657 
Figure 4. Second derivative Raman signal intensity for measurements at aspirin 658 
(1606 cm
-1
), Avicel (1095 cm
-1
) and sodium nitrate (1068 cm
-1
) peaks for increasing 659 
particle size ranges with a powder depth of 8.48 mm. The lines drawn through the data 660 
points were calculated using a cubic B-spline function. 661 
  662 
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 663 
Figure 5. Offset second derivative Raman spectra obtained at a) 50, b) 150, c) 200, d) 400 664 
and e) 800 s during the mixing of 40 g of aspirin (particle size range 250 ± 300 µm) and 665 
Avicel PH-101. Aspirin was added to Avicel at 120 s and a mixing speed of 50 rpm was 666 
used. 667 
  668 
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 669 
Figure 6. Raman PhAT probe mixing profiles at 1606 cm
-1
 for additions of a) 0, b) 5, c) 670 
10, d) 20, e) 30 and f) 40 g of aspirin (particle size range 250 ± 300 µm) to Avicel PH-671 
101 at 120 s, mixing with an impeller speed of 50 rpm. 672 
  673 
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 674 
Figure 7. Mixing profiles for addition of 30 g aspirin to 75 g Avicel PH-101 at 120 s 675 
mixing at 50 rpm, obtained simultaneously by three non-invasive techniques: a) acoustic 676 
emission spectrometry (area between 0 and 400 kHz); b) NIR spectrometry (1
st
 derivative 677 
of log(1/R) at 8956 cm
-1
), and c) Raman spectrometry (2
nd
 derivative of intensity at 678 
1606 cm
-1
). 679 
  680 
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 681 
Figure 8. Raman mixing profiles obtained using a) the aspartame peak at 1006 cm
-1
 and 682 
b) the aspirin peak at 1606 cm
-1
 for addition of 25 g aspirin (120 s) and 25 g aspartame 683 
(900 s) to 75 g Avicel PH-101 mixing at 50 rpm. 684 
